Venmax Drugs and Pharmaceuticals share news and announcements
BSE: 531015Pharmaceuticals & BiotechnologySmall Cap
Last close ₹14.48down ₹0.51 (3.40%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹14.99.
52-week range of traded prices to 23 Oct 2026
₹12.71Low, 17 Sep 2026₹31.49High, 3 Dec 2025
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹17 Cr4,053rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Not shown: another business merged into the company on 30 Jun 2026, and the accounts this figure is made of do not include it yet. It returns once accounts of the company as it now is are filed.
- Mergernew accounts awaited
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day.
- 7,037
Venmax Drugs and Pharmaceuticals routine notices
53 filed, newest first. Page 2 of 2.
Oct 2019
Sep 2019
27 Sep · Routine
Jul 2019